As of Jul 27
| +0.45 / +0.70%|
The 19 analysts offering 12-month price forecasts for AbbVie have a median target of 70.00, with a high estimate of 90.00 and a low estimate of 47.00. The median estimate represents a +7.86% increase from the last price of 64.90.
The current consensus among 21 polled investment analysts is to Buy stock in AbbVie. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.